Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 20 of 194
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Sandoz makes available biosimilar of Humira in US

The treatment is indicated for usage in areas that are not covered by the reference medicine Humira’s regulatory exclusivity. The indications include inflammatory ailments namely juvenile idiopathic arthritis,

GSK acquires pharma firm Bellus Health for $2bn

Bellus focuses on improving the lives of individuals suffering from persistent cough. In April this year, GSK reached an agreement for the acquisition of Bellus Health. The takeover comprises the